PUBLISHER: Grand View Research | PRODUCT CODE: 1908487
PUBLISHER: Grand View Research | PRODUCT CODE: 1908487
The global medical tourism market size was estimated at USD 48.40 billion in 2025 and is expected to reach an estimated value of USD 154.79 billion by 2033, growing at a CAGR of 15.58% from 2026 to 2033. Major market growth drivers include cost savings and extra benefits to visitors, such as cutting-edge technologies, enhanced healthcare, sophisticated equipment, breakthrough medicines, superior hospitality, and personalized care.
During the forecast period, the medical tourism industry is projected to advance at a breakneck pace. The high cost of health services in home countries is the primary factor driving market growth. In addition, the industry is being driven by rising demand for procedures that are not covered by insurance, such as gender reassignment surgeries, reproductive therapy, dental reconstruction, and aesthetic surgery.
In developing countries such as Thailand and Malaysia, a high-quality treatment can be availed at a lower cost than in developed countries. Even though the cost of treatments in developing countries is minimal, the quality of the procedure is not compromised due to the availability of resources at relatively lower costs. This factor leads to an influx of people seeking health services in these countries. For instance, an angioplasty procedure costs around USD 55,000 to USD 57,000 for an individual in the U.S., compared to around USD 2,500 to USD 3,500 in Malaysia. People travel for treatment from America and Europe to Singapore, Malaysia, India, and Thailand, saving between 55% and 70% on medical costs.
Global Medical Tourism Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the medical tourism market report based on treatment type, service provider, and country: